Indivior pledges to appeal generic Suboxone decision

UK-based Indivior has pledged to appeal a US court decision that found a drug developed by generics maker Alvogen doesn’t infringe three of Indivior’s patents.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

US judge invalidates Pernix patents in Alvogen clash

28 August 2018 Generics maker Alvogen secured a patent win at a US court last week, despite the judge finding that the company had infringed patents covering an opioid treatment.

Americas

Indivior obtains court order to block generic Suboxone

18 June 2018 Addiction treatment drug producer Indivior has obtained a temporary restraining order against Indian generic maker Dr Reddy’s, blocking the company from launching a generic version of Suboxone (buprenorphine and naloxone) Film.

Americas

Indivior settles addiction drug dispute with Par

16 May 2018 Addiction drug producer Indivior has settled its patent infringement dispute with generics manufacturer Par Pharmaceutical.